Homepage  /  IVF News  

IVF News



News: ART & Embryology training program

Chennai Fertility Centre and Research Institute 03 December 2024
ART & Embryology training program

Training Batch Schedule January to March 2025 

  • Batch - January              :        17th to 31st 2025
  • Batch - February             :        10th to 24th 2025
  • Batch - March                  :       10th to 24th 2025

The International School of Embryology a unit of Chennai Fertility Centre and Research Institute was established to offer training in Advanced Reproductive Techniques and Embryology for clinicians and embryologists. It will help them to know in-depth knowledge and have good hands-on training. The members of our teaching faculty aim to bring Clinician and Embryologists to the highest level of knowledge about Assisted Reproductive Technology and practical capability.

Our courses cover basics in Andrology, Embryology, ICSI & Cryosciences (Hands-on).

Limited Seats. For admission Contact  9003111598 / 8428278218 


[ Full Article ]
Share IVF News on FaceBook   Share IVF News on Twitter   

News: ART & Embryology training program

Chennai Fertility Centre and Research Institute 03 December 2024
ART & Embryology training program

Training Batch Schedule January 2025 

January : 17th to 31st 2025

The International School of Embryology a unit of Chennai Fertility Centre and Research Institute was established to offer training in Advanced Reproductive Techniques and Embryology for clinicians and embryologists. It will help them to know in-depth knowledge and have good hands-on training. The members of our teaching faculty aim to bring Clinician and Embryologists to the highest level of knowledge about Assisted Reproductive Technology and practical capability.

Our courses cover basics in Andrology, Embryology, ICSI & Cryosciences (Hands-on).

Limited Seats. For admission Contact  9003111598 / 8428278218 


[ Full Article ]
Share IVF News on FaceBook   Share IVF News on Twitter   

News: Administrative Failures at Leiden University Lead to One Donor Fathering 86 Children and 440 Individuals Exceeding 25 Half-Sibling Limit

IVF.net Newsdesk 25 November 2024

Leiden University Medical Center (LUMC) has officially acknowledged significant administrative shortcomings within its former sperm bank, revealing that one donor fathered 86 children—far exceeding the legally permitted limit. An internal investigation uncovered that sperm from nine donors was used more than the agreed-upon maximum of 25 times, resulting in 440 individuals having more half-siblings than allowed by law. In some instances, siblings discovered they had different biological fathers despite previous beliefs.

These issues first surfaced earlier this year when LUMC reported being unable to trace the donor father of 102 children conceived through its services. The hospital has since identified that 1,173 children were born using sperm from 115 different donors, assisting 754 women between 1977 and 2006, when the sperm bank was operational.

The hospital expressed deep concern over the findings and emphasized its commitment to taking full responsibility. Efforts are underway to provide transparency and clarity to all parties affected by these revelations.

This case adds to a series of fertility-related scandals in the Netherlands involving administrative chaos and unauthorized sperm use. Earlier this year, a former lab worker at a Leiden fertility clinic was found to have illegally fathered 11 children and was discovered to carry a hereditary disease. In 2022, the Donorkind Foundation identified at least ten doctors who had illicitly used their own sperm to father children, including high-profile cases such as Jan Karbaat, who fathered at least 81 children; Jan Wildschut, with at least 47 offspring; and Jos Beek, confirmed to have at least 21 children.

International attention was drawn to the issue when Dutchman Jonathan Jacob Meijer, believed to have fathered hundreds of children via sperm donation, was legally ordered to cease his activities in April last year. His case was featured in a recent Netflix documentary, highlighting the global implications of such ethical breaches.

These incidents have raised serious ethical and legal concerns about sperm donation practices, donor anonymity, and the rights of donor-conceived individuals. The revelations have prompted calls for stricter regulations, improved record-keeping, and greater transparency within fertility clinics to prevent future occurrences.

LUMC has pledged to enhance its administrative procedures and is cooperating fully with authorities to address the identified issues. Support and counseling services are being offered to affected families and individuals to help them cope with the emotional and psychological impact of these discoveries.

The confirmation of these administrative failings underscores the critical need for rigorous oversight in reproductive medicine. As reproductive technologies advance, ensuring ethical practices and safeguarding the well-being of all parties involved remain paramount concerns for the medical community and regulatory bodies alike.

 

Source

20 November 2024 - Dutch News


[ Full Article ]
Share IVF News on FaceBook   Share IVF News on Twitter   

Announcement: Joy: A Captivating Journey Behind the World’s First ‘Test-Tube Baby’ Now on Netflix

IVF.net Newsdesk 22 November 2024

The Movie “Joy” is now available on Netflix - https://www.netflix.com/watch/81701716

Netflix has recently released Joy, a compelling film directed by Ben Taylor (Sex Education), that delves into the groundbreaking journey leading to the birth of Louise Joy Brown—the world’s first “test-tube baby.” This film is particularly significant for the IVF scientific community, as it sheds light on the relentless efforts, scientific innovations, and ethical challenges faced by the pioneers of in vitro fertilization (IVF).

An In-Depth Look at IVF’s Founding Figures

“Joy” meticulously portrays the collaborative work of three pivotal figures whose contributions laid the foundation for modern reproductive medicine:

Jean Purdy (portrayed by Thomasin McKenzie), a nurse and embryologist whose critical role has often been underrepresented in historical accounts.

Robert Edwards (played by James Norton), a visionary scientist who later received the Nobel Prize for his work in human fertilization.

Patrick Steptoe (enacted by Bill Nighy), a skilled surgeon and gynecologist specializing in laparoscopy, whose surgical expertise was instrumental in the IVF process.

For professionals in the field, the film offers a nuanced depiction of the scientific rigor and perseverance required to achieve the first successful human IVF. It delves into the technical challenges of the time, such as optimizing culture media, timing of egg retrieval, and early embryo development—issues that continue to evolve in today’s practices.

 

Highlighting Jean Purdy’s Integral Role

One of the film’s most commendable achievements is its focus on Jean Purdy. Despite being one of the first to observe and document the division of a human embryo outside the body, Purdy’s contributions have been historically overshadowed. “Joy” brings her to the forefront, emphasizing her expertise in embryology and her integral role in the team’s success.

This portrayal serves as a poignant reminder to the scientific community about the importance of recognizing all contributors to significant advancements, regardless of gender. It encourages a re-examination of historical records and a commitment to inclusivity in acknowledging scientific achievements.

 

Authenticity Rooted in Research

The creators, Jack Thorne (Enola Holmes, The Swimmers) and Rachel Mason, conducted extensive research to ensure the film’s accuracy:

Archival Exploration: Accessing materials from the Churchill Archives Centre to gather original documents, lab notes, and correspondence.

Personal Interviews: Engaging with the families of Edwards, Steptoe, and Purdy to gain personal insights and anecdotes that enriched the narrative.

Scientific Consultation: Collaborating with reproductive scientists and historians to accurately depict laboratory techniques and the scientific climate of the era.

Director Ben Taylor, himself a parent through IVF, brings a personal connection to the material, further enhancing the film’s authenticity and emotional resonance.

 

A Reflection on Ethical and Societal Challenges

“Joy” doesn’t shy away from the ethical debates and societal opposition that surrounded early IVF research. It portrays:

Regulatory Hurdles: The team’s struggle to secure funding and institutional support amidst skepticism and regulatory limitations.

Public Scrutiny: The media attention and moral questions posed by the public and religious institutions.

Scientific Isolation: The professional risks taken by the team as they pursued a controversial area of research.

These aspects provide valuable context for contemporary discussions on bioethics, patient consent, and the role of public perception in scientific advancement.

 

Impact on Modern IVF Practices

For today’s IVF scientists and clinicians, “Joy” offers a historical perspective that enhances understanding of:

Technological Evolution: Appreciating how far techniques have advanced from rudimentary equipment to sophisticated assisted reproductive technologies.

Best Practices Development: Recognizing the trial-and-error process that led to current protocols in embryo culture, cryopreservation, and genetic screening.

Patient-Centered Care: Reflecting on the emotional journey of patients and the importance of empathy and ethical responsibility in reproductive medicine.

 

Educational Value for the Scientific Community

“Joy” can serve as an educational tool within academic and professional settings:

Training Programs: Supplementing curricula for embryologists, reproductive endocrinologists, and medical students specializing in reproductive sciences.

Ethics Seminars: Facilitating discussions on the moral implications of assisted reproductive technologies and the evolution of ethical standards.

Historical Context: Providing a narrative that contextualizes current practices within the rich history of reproductive medicine.

 

A Catalyst for Recognizing Unsung Heroes

By bringing Jean Purdy’s story to light, the film encourages the scientific community to:

Reevaluate Historical Narratives: Ensuring that all contributors receive appropriate recognition in scientific history.

Promote Diversity and Inclusion: Advocating for equal representation and acknowledgment of scientists regardless of gender or background.

Inspire Future Generations: Motivating young scientists, particularly women, to pursue careers in STEM fields.

 

Conclusion

“Joy” is more than a cinematic experience; it’s a tribute to the resilience, ingenuity, and collaborative spirit that define the field of IVF. It honors the legacy of Edwards, Steptoe, and Purdy, whose collective efforts have enabled millions of individuals worldwide to experience parenthood.

 

Now Streaming on Netflix

We highly recommend that IVF professionals, researchers, and students watch “Joy” to gain deeper insights into the origins of our field. The film not only celebrates past achievements but also inspires continued innovation and ethical commitment in reproductive medicine. [https://www.netflix.com/watch/81701716]


[ Full Article ]
Share IVF News on FaceBook   Share IVF News on Twitter   

Webinar: ENDGAME - Available to watch

International IVF Initiative 12 November 2024
ENDGAME - Available to watch

3pm ET/ 8pm UK/ 9pm CET, Tuesday 19th Nov 2024

Moderators:
Dr. Markella Mikkelsen and Edel Rocher

Presenters:
Dr. Yorgos Nikas: Microcosmos: endometrial disorders affecting implantation revealed by scanning electron microscopy

Dr. Laura Medina: Endometrial microbiota: Effect on assisted reproduction treatments
A talk kindly sponsored by IGLS

Jullin Fjeldstad: Endometrics
A talk kindly sponsored by Future Fertility

Q and A

WATCH HERE


[ Full Article ]
Share IVF News on FaceBook   Share IVF News on Twitter   

Webinar: 24hr IVF QC

International IVF Initiative 03 November 2024

Presenter: Jean Popwell, Laboratory QA Director, Inception Fertility

Overview:

Jean Popwell’s presentation focused on the critical importance of comprehensive equipment monitoring in IVF laboratories. While the College of American Pathologists (CAP) requires a daily quality control (QC) check for specific equipment, Popwell questioned if this is sufficient, highlighting potential gaps that could compromise the integrity of gametes, embryos, and other critical materials.

Key Equipment Monitored:

Critical Equipment: Cryo tanks and dewars, incubators, refrigerators, freezers, room humidity, and temperature.

Non-Critical Equipment: Workbenches, warmers, and water baths.

Central Monitoring Command Center (CMCC):

Popwell introduced the CMCC, a centralized system providing overall surveillance of all network laboratories. The CMCC offers:

• Real-time observation of alerts, statuses, and responses.

• Assurance of monitoring system integrity across labs.

• Remote access to live data and thermographic images.

Integration with Reflections QC App:

Efficiency Gains: By integrating the CMCC with the Reflections QC reporting app, laboratories can automatically import equipment temperature data into daily QC logs.

Time Savings: This integration reduces QC data entry time by up to 1–1.5 hours per day in medium to large labs.

Ease of Use: A simple “Import Auto Values” feature populates QC logs with current data, minimizing manual entry and errors.

Redundant Lab Monitoring with CryoSentinel:

Thermographic Camera System (CryoSentinel): Provides continuous thermal imaging of cryo storage areas to detect surface temperature shifts indicative of potential vacuum failures in tanks and dewars.

Dual Alert System: Alerts from both the thermographic cameras and probe systems ensure no critical event goes unnoticed.

Live Video Feeds: Offer immediate visual assessments of the lab environment and equipment status.

Benefits of 24-Hour Monitoring:

Detection of Equipment Trends and Anomalies: Continuous data tracking uncovers patterns and deviations not apparent in once-daily checks.

Preventative Action: Early identification of equipment issues allows for timely interventions before catastrophic failures occur.

Optimized Lab Workflow: Insights into equipment performance can lead to improved scheduling and utilization of lab resources.

Enhanced Compliance: Supports adherence to regulatory standards by providing comprehensive documentation of equipment performance.

Examples Highlighted:

Incubators: Identified temperature fluctuations and erratic behavior over time, prompting investigations into equipment reliability.

Refrigerators and Freezers: Revealed cycling issues and temperature spikes when adding new inventory, leading to adjustments in stocking procedures.

Room Humidity and Temperature: Showed significant variations due to seasonal changes and HVAC settings, affecting overall lab conditions.

Non-Critical Equipment: Monitored recovery times and temperature stability of warmers and workbenches during frequent use and adjustments.

Conclusion:

Jean Popwell advocated for the adoption of 24-hour monitoring systems like CryoSentinel in IVF laboratories, emphasizing that there are virtually no downsides. Such systems enhance equipment oversight, safeguard the integrity of biological materials, and contribute to better patient outcomes. By leveraging advanced monitoring technologies and integrating them with QC processes, laboratories can achieve higher efficiency, reliability, and compliance.

Recommendations:

Implement Comprehensive Monitoring Dashboards: Choose systems that offer an administrative overview of all equipment and locations.

Utilize Data Integration: Incorporate monitoring data into QC software to streamline reporting and save time.

Develop Data-Driven SOPs: Use equipment performance trends to inform standard operating procedures and equipment selection.

Plan for Equipment Lifecycle Management: Identify when to retire or service equipment based on performance data before failures occur.

Final Note:

Embracing 24-hour equipment monitoring is a proactive step toward excellence in IVF laboratory operations. Systems like CryoSentinel not only provide peace of mind but also play a pivotal role in maintaining the highest standards of patient care and laboratory excellence.


[ Full Article ]
Share IVF News on FaceBook   Share IVF News on Twitter   

News: Bridging the Mystery of Fertilization: A Conserved Complex Connects Sperm and Egg Across Vertebrates

IVF.net Newsdesk 03 November 2024

Fertilization is one of life's most profound events, a moment where two cells unite to begin the journey of creating new life. Yet, despite its fundamental importance, the intricate molecular dance that allows a sperm and an egg to recognize, bind, and fuse with each other has long remained a mystery. Recently, a groundbreaking study led by Victoria E. Deneke has shed new light on this process, revealing a conserved protein complex that acts as a bridge between sperm and egg across a wide range of vertebrate species.

For years, scientists have been fascinated by the question of how sperm and egg cells find and fuse with each other to initiate development. While it's known that specific proteins on the surfaces of these cells are crucial for their interaction, the detailed mechanisms have been elusive. In mammals, proteins like IZUMO1 on sperm and JUNO on eggs have been identified as essential players. But these discoveries were just pieces of a larger, more complex puzzle.

Deneke and her team took an innovative approach to unravel this mystery. They utilized AlphaFold-Multimer, a cutting-edge protein structure prediction tool, to explore how certain sperm proteins might interact with each other and with potential partners on the egg. Focusing on proteins known to be conserved across vertebrates—IZUMO1, SPACA6, DCST1, and DCST2—they embarked on a comprehensive computational analysis.

Their findings were both unexpected and exciting. The computational models predicted that IZUMO1, SPACA6, and a less-studied protein called TMEM81 form a trimeric complex on the surface of sperm cells. This wasn't just a random assembly; the predicted complex suggested a specific arrangement where these three proteins interact intimately, potentially forming a crucial bridge during fertilization. Even more compelling was the observation that this complex appeared to be conserved not just in one species but across a range of vertebrates, including humans.

TMEM81 emerged as a particularly intriguing player. Previously not associated with fertilization, this protein hadn't been given much attention in reproductive biology. To test their predictions, the researchers conducted experiments using zebrafish and mice genetically engineered to lack TMEM81. The results were striking. Male zebrafish and mice without TMEM81 were sterile. Their sperm looked normal under the microscope and moved properly, but they couldn't successfully bind to or fuse with eggs. This provided strong evidence that TMEM81 is essential for male fertility and plays a critical role in the fertilization process.

Delving deeper, the team explored how this sperm complex interacts with proteins on the egg. In zebrafish, they focused on a protein called Bouncer, previously identified as essential for fertilization in fish. Through a series of clever experiments, they demonstrated that the sperm trimer binds directly to Bouncer on the egg. This interaction effectively creates a physical and functional bridge between the sperm and egg, facilitating their union.

In mammals, the scenario is slightly different but follows a similar theme. Instead of Bouncer, the egg protein JUNO interacts with IZUMO1 on the sperm. Despite differences in the egg proteins involved, the fundamental mechanism—a conserved sperm complex binding to an egg protein to enable fertilization—appears to be a common thread across vertebrates. This finding suggests that while the sperm machinery has remained relatively unchanged through evolution, the egg's receptors have adapted and diverged, possibly in response to different reproductive strategies and environmental pressures.

The researchers didn't stop at computational predictions and animal models. They went further to validate their findings in human cells. By expressing the human versions of IZUMO1, SPACA6, and TMEM81 in cultured cells, they demonstrated that these proteins could indeed interact, forming a complex similar to that predicted computationally. This cross-species validation strengthened the case that the mechanism uncovered in zebrafish and mice is relevant to human biology.

This discovery has profound implications. Infertility affects millions of people worldwide, and in many cases, the underlying causes remain unknown. By unveiling a key component of the fertilization process, this research opens new avenues for understanding certain types of male infertility. It provides potential targets for diagnostic tools and treatments that could help couples struggling to conceive.

Moreover, the identification of a conserved fertilization mechanism offers exciting possibilities for contraception. Developing methods to disrupt this critical protein complex could lead to novel contraceptives that are highly specific, potentially with fewer side effects than current options.

Beyond practical applications, there's something deeply inspiring about uncovering the molecular details of fertilization. It's a reminder of the elegance and complexity of biological systems, and how even processes that seem straightforward can involve intricate interactions honed by millions of years of evolution.

This study is a testament to the power of modern science, blending computational prowess with biological experimentation. It demonstrates how interdisciplinary approaches can lead to significant breakthroughs, solving puzzles that have confounded researchers for decades.

As we look ahead, this discovery opens the door to numerous new questions. How exactly does the sperm complex trigger the subsequent steps leading to fusion? Are there other, yet undiscovered proteins involved? How do these mechanisms vary across different species, and what can that tell us about evolution and adaptation?

Each answer brings us closer to a fuller understanding of one of life's most fundamental processes. Fertilization is not just the beginning of an individual life; it's a key event that has shaped the diversity of life on Earth. By studying it, we gain insights not only into biology but also into the history of life itself.

Deneke's study marks a significant advancement in reproductive biology, illuminating a conserved mechanism that bridges sperm and egg. It's a reminder that even in areas we've studied for centuries, there are still mysteries to unravel and discoveries to make. As research continues, we can expect more exciting revelations about the fundamental processes that drive life.


Source

Cell, October 17, 2024. A conserved fertilization complex bridges sperm and egg in vertebrates


[ Full Article ]
Share IVF News on FaceBook   Share IVF News on Twitter   

News: Scientists Discover "Pause Button" in Human Development

IVF.net Newsdesk 03 November 2024

Findings have possible implications for reproductive technologies

Researchers from the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin and the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna have uncovered a mechanism that may allow for a "pause button" in the earliest stages of human development. This discovery could have significant implications for our understanding of early human life and potential applications in reproductive technologies.

Unveiling a Dormant State in Human Cells

In certain mammals, embryonic development can be temporarily halted—a process known as embryonic diapause—to enhance the survival prospects of both the embryo and the mother. This pause typically occurs at the blastocyst stage, just before the embryo implants in the uterus, and can extend pregnancy for weeks or even months until conditions become favorable for continued development.

While embryonic diapause is well-documented in some species, it remained unclear whether human cells possess a similar capability. Research teams from MPIMG and IMBA investigated this possibility using human stem cells and stem cell-derived blastocyst models known as blastoids.

The Role of the mTOR Signaling Pathway

Using blastoids as an ethical and scientific alternative to human embryos, the scientists discovered that modulating the mechanistic target of rapamycin (mTOR) signaling pathway—a crucial regulator of cell growth and development—could induce a dormant state in these models. Treatment of human stem cells and blastoids with an mTOR inhibitor resulted in a developmental delay, suggesting that human cells can activate the molecular machinery to enter a diapause-like state.

During this induced dormancy, cells exhibited reduced division rates, slower development, and a decreased ability to attach to the uterine lining. Notably, this dormant state was reversible; once the mTOR pathway was reactivated, the blastoids resumed normal development. The capacity to enter dormancy appeared limited to a specific window in early development, aligning with the blastocyst stage where diapause occurs in other mammals.

Implications for Reproductive Medicine

The findings suggest that humans may retain an inherent mechanism to temporarily slow down embryonic development, even if it is not naturally utilized during pregnancy. Although this mechanism might be an evolutionary vestige that is no longer employed, the experiments indicate that this capability exists at a cellular level and could potentially be harnessed.

Controlling the timing of embryonic development holds promising implications for reproductive technologies such as in vitro fertilization (IVF). Enhancing mTOR activity could accelerate development, which is known to improve IVF success rates. Conversely, inducing a dormant state during IVF could provide a larger window to assess embryo health and better synchronize implantation with the mother's uterine environment.

A Collaborative Effort Advancing Science

The study highlights the power of collaborative research in tackling complex biological questions. By bringing together diverse expertise, the researchers advanced the understanding of fundamental processes governing early human development. Their work opens up new avenues for exploring how cells interpret various signals as they embark on their developmental journey.

Future Directions

The researchers aim to further investigate whether human and other mammalian cells utilize similar or distinct pathways to enter dormancy and how this mechanism can be applied for clinical benefits. Understanding the intricacies of this "pause button" could lead to innovations in reproductive health and provide deeper insights into the earliest stages of human life.

Sources


[ Full Article ]
Share IVF News on FaceBook   Share IVF News on Twitter   

News: ART & Embryology training program

Chennai Fertility Centre and Research Institute 01 November 2024
ART & Embryology training program

Training Batch Schedule  for December 2024  

  • December     =     16th to 31st 2024

The International School of Embryology a unit of Chennai Fertility Centre and Research Institute was established to offer training in Advanced Reproductive Techniques and Embryology for clinicians and embryologists. It will help them to know in-depth knowledge and have good hands-on training. The members of our teaching faculty aim to bring Clinician and Embryologists to the highest level of knowledge about Assisted Reproductive Technology and practical capability.

Our courses cover basics in Andrology, Embryology, ICSI & Cryosciences (Hands-on).

Limited Seats. For admission Contact  9003111598 / 8428278218 


[ Full Article ]
Share IVF News on FaceBook   Share IVF News on Twitter   

Conference: FetusCon24 Jabalpur India

Dr. D'Pankar Banerji 11 October 2024

FetusCon24 on 26th and 28th October 2024 as Fetus day celebration.

Fetus day (31October) celebrated since 2010 by Ideal Fertility along with Jabalpur Obstetrics and Gynecology society as one/two day CME every year. Care starts before conception and during Fertility treatment, at embryo stage and early pregnancy to prevent aneuploidy and various genetic disorders atthe beginning .It's a spectrum of care begins at the time of planning a family.


[ Full Article ]
Share IVF News on FaceBook   Share IVF News on Twitter   



Join Our Newsletter - Don't Miss Anything!!!

Stay in touch with the latest news by subscribing to our regular email newsletters